Script Training for Aphasia
(MIDAS Trial)
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants should not be receiving speech-language therapy at the time of the study.
Research shows that script training, including computer-based methods, can significantly improve speech and language skills in people with aphasia, helping them use practiced phrases in real conversations. This approach is effective for both stable and progressive forms of aphasia, and improvements can be maintained over time.
12345The research does not report any safety concerns related to script training for aphasia, suggesting it is generally safe for humans.
14567Script training for aphasia is unique because it involves practicing specific phrases and sentences repeatedly, which can be used in real-life conversations. This treatment can be delivered via computer with a virtual clinician, allowing for flexible and intensive practice, and it has been shown to improve communication in both stable and progressive forms of aphasia.
12358Eligibility Criteria
This trial is for men and women who have aphasia after a left-hemisphere stroke. They should be at least 6 months post-stroke, with an Aphasia Quotient score of 40-80 on the Western Aphasia Battery-Revised. Participants must have completed eighth grade, be literate in English, not currently receiving speech therapy, and have adequate vision and hearing. Those with active substance abuse, other neurological conditions affecting cognition/speech or significant psychiatric history are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants practice conversational scripts using a computer-based speech and language therapy program. The practice varies between 2 weeks (5 days a week) and 5 weeks (2 days a week) depending on the assigned group.
Follow-up
Participants are monitored for maintenance of trained script and generalization of conversation skills.
Participant Groups
Modulating Intensity and Dosage of Aphasia Scripts is already approved in United States, European Union, Canada for the following indications:
- Aphasia following stroke
- Aphasia following stroke
- Language disorders
- Aphasia following stroke
- Language disorders